|
1）American Academy of Sleep Medicine. The International classification of sleep disorder. 3rd ed. Darien: American Academy of Sleep Medicine; 2014
|
|
|
|
|
2）Bassetti CL, Mauerhofer D, Gugger M, et al. Restless legs syndrome: a clinical study of 55 patients. Eur Neurol. 2001; 45: 67-74
|
|
|
|
|
3）Hening WA. Restless legs syndrome: a sensorimotor disorder of sleep/wake motor regulation. Curr Neurol Neurosci Rep. 2002; 2: 186-96
|
|
|
|
|
|
4）Ohayon MM, OʼHara R, Vitello MV. Epidemiology of restless legs syndrome: A synthesis of the literature. Sleep Med Rev. 2012; 16: 283-95
|
|
|
|
|
|
5）Yeh P, Walters AS, Tsuang W. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath. 2012; 16: 987-1007
|
|
|
|
|
|
6）Gjerstad MD, Tysnes OB, Larsen JP. Increased risk of leg motor restlessness but not RLS in early Parkinson disease. Neurology. 2011; 77: 1941-6
|
|
|
|
|
|
7）The International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless leg syndrome. Sleep Med. 2003; 4: 121-32
|
|
|
|
|
|
8）Montplaisir J, Boucher S, Nicolas A, et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless legs syndrome. Mov Disord. 1998; 13: 324-9
|
|
|
|
|
|
9）Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010; 6: 337-46
|
|
|
|
|
|
10）Clemens S, Hochman S. Conversion of the modulatory actions of dopamine on spinal reflexes from depression to fasciliation in D3 receptor knock-out mice. J Neurosci. 2004; 24: 11337-45
|
|
|
|
|
|
11）Zhao H, Zhu W, Pan T, et al. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation. J Neurosci Res. 2007; 85: 1065-76
|
|
|
|
|
|
12）Clemens S, Rye D, Hochman S. Restless legs syndrome: Revisiting the dopamine hypothesis from the spinal cord perspective. Neurology. 2006; 67: 125-30
|
|
|
|
|
|
13）Allen RP, La Buda MC, Becker P, et al. Family history study of the restless legs syndrome. Sleep Med. 2002; 3: S3-S7
|
|
|
|
|
|
14）Stefansson H, Rye DB, Hicks A, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med. 2007; 357: 639-47
|
|
|
|
|
|
15）Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nature Genetics 2007; 39: 1000-6
|
|
|
|
|
|
16）Winkelman J. Genetics of restless legs syndrome. Curr Neurol Neurosci Rep. 2008; 8: 211-6
|
|
|
|
|
|
17）Catoire H, Dion PA, Xiong L, et al. Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis. Ann Neurol. 2011; 70: 170-5
|
|
|
|
|
|
18）Garcia-Borreguero D, Stillman P, Benes H, et al. Algorithms for the diagnosis and treatment of restless legs syndrome in primary care. BMC Neurology. 2011; 11: 28
|
|
|
|
|
|
19）Garcia-Borreguero D, Allen RP, Kohnen R, et al. Diagnostic Standards for Dopaminergic Augmentation of Restless Legs Syndrome: Report from a World Association of Sleep Medicine - International Restless Legs Syndrome Study Group Consensus Conference at the Max Planck Institute. Sleep Med. 2007; 8: 520-30
|
|
|
|
|
|
20）Garcia-Borregero D, Kohnen R, Silber MH, et al. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidlines and clinical consencsus best practice guidance: a report from the International Retless Legs Syndrome Study Group. Sleep Med. 2013; 14: 675-84
|
|
|
|
|